Mifamurtide vs Thymogen
Head-to-head comparison of Mifamurtide (Muramyl Tripeptide Phosphatidylethanolamine) and Thymogen (L-Glutamyl-L-Tryptophan) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Mifamurtide | Thymogen |
|---|---|---|
| Category | Immune Support | Immune Support |
| Full Name | Muramyl Tripeptide Phosphatidylethanolamine | L-Glutamyl-L-Tryptophan |
| Molecular Weight | N/A | 345.34 Da |
| Half-Life | 2-4 h | 1-2 h |
| Amino Acids | N/A | 2 |
| Typical Dose | 2 mg/m2 | 100-300 mcg |
| Route | Intravenous | Intranasal |
| Purity | ≥98% | ≥98% |
| Studies Count | 150 | 60 |
| Research Status | Clinical | Clinical |
Mifamurtide Benefits
- ✓macrophage-activation
- ✓innate-immune-signaling
- ✓immune-adjuvant-research
- ✓cytokine-response
Thymogen Benefits
- ✓cellular-immune-support
- ✓t-cell-signaling
- ✓recovery-adjunct
- ✓infection-resilience
Mifamurtide Dosing
2 mg/m2 IV|2x weekly for 12 weeks|then weekly for 24 weeks in approved regimens
Thymogen Dosing
100-300 mcg/day|intranasal or IM|5-10 day cycles
Mifamurtide Side Effects
- ⚠fever/chills
- ⚠fatigue
- ⚠nausea
Thymogen Side Effects
- ⚠nasal irritation
- ⚠headache
- ⚠hypersensitivity
Research Overview
Mifamurtide
Mifamurtide has substantial literature as an innate immune activator and is an approved oncology adjunct in some regions. Research centers on NOD-like receptor signaling, macrophage activation, and downstream cytokine effects.
Thymogen
Thymogen has been studied as a short thymic peptide-like dipeptide with immunoregulatory activity. The literature focuses on lymphocyte function, cytokine modulation, and use in recurrent respiratory infections or immune suppression states.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.